ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES
With purpose to assess the volume and rationality of prescription of medicines for the community-acquired pneumonia (CAP) treatment in patients with chronic comorbidities a prospective study of 438 in-patients (214 men (48.9%), average age - 56,1 ± 17,9) was conducted. Chronic comorbidities were in...
Saved in:
Main Author: | A.V. Demchuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Poltava State Medical University
2017-03-01
|
Series: | Проблеми екології та медицини |
Subjects: | |
Online Access: | https://ecomed-journal.org/index.php/journal/article/view/51 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMMUNITY-ACQUIRED PNEUMONIA COMPLICATED BY SEPSIS CAUSED BY KLEBSIELLA PNEUMONIAE: A CASE REPORT
by: A.V. Lavrenko
Published: (2017-12-01) -
The effect of immunosuppression on outcomes in elderly patients with community-acquired pneumonia
by: Lixue Huang, et al.
Published: (2025-01-01) -
THE COURSE OF ACUTE RESPIRATORY COVID-19 DISEASE, COMPLICATED BY COMMUNITY-ACQUIRED PNEUMONIA AGAINST THE BACKGROUND OF THE CARDIOVASCULAR SYSTEM PATHOLOGY
by: T.A. Trybrat, et al.
Published: (2021-08-01) -
The incidence of radiologically verified community-acquired pneumonia requiring hospitalisation in adults living in southern Sweden, 2016-2018: a population-based study
by: Elisabeth Rünow, et al.
Published: (2025-01-01) -
Signatures of lower respiratory tract microbiome in children with severe community-acquired pneumonia using shotgun metagenomic sequencing
by: Ting-Yu Yen, et al.
Published: (2025-02-01)